Those following along with Biodesix, Inc. (NASDAQ:BDSX) will no doubt be intrigued by the recent purchase of shares by Jack Schuler, Independent Director of the company, who spent a stonking US$1.0m on stock at an average price of US$10.02. There's no denying a buy of that magnitude suggests conviction in a brighter future, although we do note that proportionally it only increased their holding by 4.2%.
In fact, the recent purchase by Independent Director Jack Schuler was not their only acquisition of Biodesix shares this year. They previously made an even bigger purchase of US$1.2m worth of shares at a price of US$11.81 per share. That means that an insider was happy to buy shares at above the current price of US$9.88. It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. Jack Schuler was the only individual insider to buy during the last year.
Jack Schuler bought a total of 325.07k shares over the year at an average price of US$12.67. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
View our latest analysis for Biodesix
Biodesix is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 40% of Biodesix shares, worth about US$43m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. Given that insiders also own a fair bit of Biodesix we think they are probably pretty confident of a bright future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Be aware that Biodesix is showing 3 warning signs in our investment analysis, and 2 of those are significant...
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.